Virga, A.; Gianni, C.; Palleschi, M.; Angeli, D.; Merloni, F.; Maltoni, R.; Ulivi, P.; Martinelli, G.; De Giorgi, U.; Bravaccini, S.
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024, 12, 2183.
https://doi.org/10.3390/biomedicines12102183
AMA Style
Virga A, Gianni C, Palleschi M, Angeli D, Merloni F, Maltoni R, Ulivi P, Martinelli G, De Giorgi U, Bravaccini S.
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines. 2024; 12(10):2183.
https://doi.org/10.3390/biomedicines12102183
Chicago/Turabian Style
Virga, Alessandra, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, and Sara Bravaccini.
2024. "A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors" Biomedicines 12, no. 10: 2183.
https://doi.org/10.3390/biomedicines12102183
APA Style
Virga, A., Gianni, C., Palleschi, M., Angeli, D., Merloni, F., Maltoni, R., Ulivi, P., Martinelli, G., De Giorgi, U., & Bravaccini, S.
(2024). A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines, 12(10), 2183.
https://doi.org/10.3390/biomedicines12102183
